Topical drug delivery: History, percutaneous absorption, and product development

被引:129
作者
Roberts, Michael S. [1 ,2 ,3 ]
Cheruvu, Hanumanth S. [1 ]
Mangion, Sean E. [2 ,3 ,4 ]
Alinaghi, Azadeh [2 ,3 ]
Benson, Heather A. E. [5 ]
Mohammed, Yousuf [1 ]
Holmes, Amy [2 ,3 ]
van der Hoek, John [6 ]
Pastore, Michael [2 ,7 ]
Grice, Jeffrey E. [1 ]
机构
[1] Univ Queensland, Diamantina Inst, Therapeut Res Ctr, Woolloongabba, Qld, Australia
[2] Univ South Australia, UniSA Clin & Hlth Sci, Adelaide, SA, Australia
[3] Queen Elizabeth Hosp, Basil Hetzel Inst Translat Hlth Res, Therapeut Res Ctr, Adelaide, SA, Australia
[4] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[5] Curtin Univ, Curtin Med Sch, Perth, WA, Australia
[6] Univ South Australia, UniSA STEM, Adelaide, SA, Australia
[7] Genoskin, Toulouse, France
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Topical drug delivery; Skin and its appendages; History; Mechanism; Percutaneous absorption; Product development; QSPR; PBPK; IVPT; Finite dose; Clearance; Bioequivalence; Heterogeneity; Consumer behavior; HUMAN STRATUM-CORNEUM; PENETRANT STRUCTURE RELATIONSHIPS; HUMAN SKIN BARRIER; UNDERLYING TISSUE PHARMACOKINETICS; BINDING CASSETTE TRANSPORTERS; ESTIMATING DERMAL ABSORPTION; MICROSCOPIC DIFFUSION-MODEL; IN-VITRO; HUMAN-EPIDERMIS; FOLLICULAR PENETRATION;
D O I
10.1016/j.addr.2021.113929
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Topical products, widely used to manage skin conditions, have evolved from simple potions to sophisticated delivery systems. Their development has been facilitated by advances in percutaneous absorption and product design based on an increasingly mechanistic understanding of drug-product-skin interactions, associated experiments, and a quality-by-design framework. Topical drug delivery involves drug transport from a product on the skin to a local target site and then clearance by diffusion, metabolism, and the dermal circulation to the rest of the body and deeper tissues. Insights have been provided by Quantitative Structure Permeability Relationships (QSPR), molecular dynamics simulations, and dermal Physiologically Based PharmacoKinetics (PBPK). Currently, generic product equivalents of reference listed products dominate the topical delivery market. There is an increasing regulatory interest in understanding topical product delivery behavior under 'in use' conditions and predicting in vivo response for population variations in skin barrier function and response using in silico and in vitro findings. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:43
相关论文
共 50 条
  • [21] MICROSPONGES: AS A TOPICAL DRUG DELIVERY SYSTEM
    Sharma, Shailesh
    Sharma, Anu
    Kaur, Chamanpreet
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (02): : 524 - 534
  • [22] Lanolin-Based Synthetic Membranes as Percutaneous Absorption Models for Transdermal Drug Delivery
    Carrer, Victor
    Guzman, Beatriz
    Marti, Meritxell
    Alonso, Cristina
    Coderch, Luisa
    PHARMACEUTICS, 2018, 10 (03):
  • [23] Nanoparticles and nanofibers for topical drug delivery
    Goyal, Ritu
    Macri, Lauren K.
    Kaplan, Hilton M.
    Kohn, Joachim
    JOURNAL OF CONTROLLED RELEASE, 2016, 240 : 77 - 92
  • [24] The application of feature selection to the development of Gaussian process models for percutaneous absorption
    Lam, Lun Tak
    Sun, Yi
    Davey, Neil
    Adams, Rod
    Prapopoulou, Maria
    Brown, Marc B.
    Moss, Gary P.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (06) : 738 - 749
  • [25] Advances in Topical Drug Delivery System: Micro to Nanofibrous Structures
    Joshi, Mangala
    Butola, B. S.
    Saha, Kasturi
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2014, 14 (01) : 853 - 867
  • [26] Galactosyl Pentadecene Reversibly Enhances Transdermal and Topical Drug Delivery
    Kopecna, Monika
    Machacek, Miloslav
    Prchalova, Eva
    Stepanek, Petr
    Drasar, Pavel
    Kotora, Martin
    Vavrova, Katerina
    PHARMACEUTICAL RESEARCH, 2017, 34 (10) : 2097 - 2108
  • [27] Development of a new delivery system consisting in "drug - in cyclodextrin - in nanostructured lipid carriers" for ketoprofen topical delivery
    Cirri, M.
    Bragagni, M.
    Mennini, N.
    Mura, P.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 80 (01) : 46 - 53
  • [28] Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams
    Mohammed, Y. H.
    Namjoshi, S. N.
    Jung, N.
    Windbergs, M.
    Benson, H. A. E.
    Grice, J. E.
    Raney, S. G.
    Roberts, M. S.
    PHARMACEUTICAL RESEARCH, 2024, 41 (07) : 1507 - 1520
  • [29] Research Techniques Made Simple: Drug Delivery Techniques, Part 2: Commonly Used Techniques to Assess Topical Drug Bioavailability
    Patel, Parth
    Schmieder, Shawn
    Krishnamurthy, Karthik
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : E43 - E49
  • [30] A two-phase two-layer model for transdermal drug delivery and percutaneous absorption
    Pontrelli, Giuseppe
    de Monte, Filippo
    MATHEMATICAL BIOSCIENCES, 2014, 257 : 96 - 103